Showing 341-350 of 352 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Co-transplantation of adaptive human endothelium and islets within encapsulated angiogenic hydrogels for durable engraftment | Weill Medical College of Cornell University | Shahin Rafii | Cures | 01-December-2023 to 30-November-2026 | $1,000,000.00 |
| Role of oxidative post-translational modifications in generating neoepitopes | Weill Medical College of Cornell University | Laura Santambrogio | Cures | 01-April-2025 to 31-March-2028 | $600,000.00 |
| Intrinsic Tolerance in GINS: Dissecting the HVEM/BTLA Axis Driving Hypoimmunogenicity | Weill Medical College of Cornell University | Anna Ada Dattoli | Cures | 01-April-2026 to 31-March-2027 | $199,999.32 |
| Spatial and temporal regulation of proangiogenic factors to support islet cell transplantation | William Marsh Rice University | Omid Veiseh | Cures | 01-January-2025 to 31-December-2027 | $900,000.00 |
| Localized immunomodulation for long term survival of beta islets in nonhuman primates | William Marsh Rice University | Omid Veiseh | Cures | 01-May-2026 to 30-April-2028 | $2,013,056.40 |
| Understanding Role of B cells in the pathogenesis of Type 1 Diabetes and Multiple Sclerosis | Yale University | Yoshiaki Yasumizu | Cures | 01-September-2025 to 31-August-2026 | $149,191.66 |
| Engineering inflammation resistant beta cells | Yale University | Kevan Herold | Cures | 01-September-2023 to 31-August-2026 | $499,999.37 |
| Home-based oral glucose tolerance test for type 1 diabetes screening | Yale University | Jennifer Sherr | Cures | 01-April-2025 to 31-March-2027 | $347,849.00 |
| Harnessing hematopoietic function in acute lymphoblastic leukemia to treat type 1 diabetes | Yale University | David Alagpulinsa | Cures | 01-March-2025 to 28-February-2030 | $991,634.17 |
| Genetic variation in RPS26 modulates beta-cell vitality and immunogenicity in type 1 diabetes | Yale University | David Alagpulinsa | Cures | 01-April-2026 to 31-March-2027 | $199,959.68 |